Candel Therapeutics (CADL) Accumulated Depreciation (2020 - 2025)
Candel Therapeutics (CADL) posted Accumulated Depreciation of $3.6 million for Q4 2025, up 3.82% sequentially from $3.4 million in Q3 2025, and up 15.67% YoY from $3.1 million in Q4 2024.
Candel Therapeutics (CADL) Accumulated Depreciation (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Accumulated Depreciation for 6 years, with the latest figure at $3.6 million in Q4 2025.
- Quarterly Accumulated Depreciation rose 15.67% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (up 15.67% YoY) and the FY2025 annual result came in at $3.6 million, up 15.67% from the prior year.
- Accumulated Depreciation improved to $3.6 million in Q4 2025 per CADL's latest filing, from $3.4 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $3.6 million in Q2 2025 and troughed at $167000.0 in Q2 2021.
- A 5-year average of $1.9 million and a median of $1.8 million in 2023 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation soared 383.51% in 2022, then advanced 15.67% in 2025.
- Over 5 years, Accumulated Depreciation stood at $352000.0 in 2021, then jumped by 220.74% to $1.1 million in 2022, then soared by 85.03% to $2.1 million in 2023, then surged by 47.25% to $3.1 million in 2024, then advanced by 15.67% to $3.6 million in 2025.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $3.6 million, $3.4 million, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 909,000.00 |
| Jun 30, 2022 | 704,000.00 |
| Mar 31, 2022 | 517,000.00 |
| Dec 31, 2021 | 352,000.00 |
| Sep 30, 2021 | 188,000.00 |
| Jun 30, 2021 | 167,000.00 |
| Dec 31, 2020 | 134,000.00 |